Silybin supplementation during HCV therapy with pegylated interferon-α plus ribavirin reduces depression and anxiety and increases work ability.

Giulia MalaguarneraGaetano BertinoGiuseppe ChisariMassimo MottaMichele VecchioMarco VacanteFilippo CaraciCarmela GrecoFilippo DragoGiuseppe NunnariMichele Malaguarnera

Published in: BMC psychiatry (2016)

NCT01957319 , First received: September 25, 2013. Last updated: September 30, 2013 (retrospectively registered).

Keyphrases

hepatitis c virus
dendritic cells
immune response
bone marrow
replacement therapy